Clinical trials
Follow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Lo.Li. Pharma
Rome, Lazio, Italylolipharma.it ↗
- Ownership
- Private
- Employees
- ~75
- Development stage
- Other
01
Overview
Lo.Li. Pharma has pioneered the use of myo-inositol for PCOS and fertility, with clinical trials demonstrating increased ovulation rates in women with PCOS.[2] Their Inofolic line remains a market leader over a decade after launch.[2]
- Therapeutic areas
- Men's HealthEndocrinologyInfectious DiseasesWomen's Health
- Modalities
- Dietary supplements (notably inositol-based products)Medical devices[1][2][4]Cosmetics[1]
- Industry
- Food & Nutrition
02
Partnerships
Over sixty global distribution partners including Exeltis Philippines and Exeltis Hungary for international commercialization of key brands like Inofolic.[7]
Beyond the preview
Go deeper on Lo.Li. Pharma.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Licensing & deals
Explore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Trace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Compare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Explore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Connect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Lo.Li. Pharma.